Ozmosi | Fytic acid Drug Profile

Product Description

Mechanisms of Action: NKT Stimulant

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Subcutaneous, Oral

FDA Designation: *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: GSK
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Hypotension|Exocrine Pancreatic Insufficiency

Phase 3: Calcinosis|Aortic Diseases|Aortic Valve Stenosis|Heart Valve Diseases

Phase 1: Bipolar Disorder

Trial ID	Trial	Phase	Trial Status	Disease	Primary Completion Date	Latest Trial Update Date	Data Updated
NCT05273710	ZnCl2	N/A	Completed	Other	2022-11-16	2022-12-22	Primary Completion Date\|Primary Endpoints\|Study Completion Date\|Treatments\|Trial Status
NCT04872140	NCT04872140	N/A	Completed	Anemia, Iron-Deficiency	2022-06-30	2022-10-14	Patient Enrollment\|Primary Endpoints\|Treatments\|Trial Status
ACTRN12620000917932	CGM-ICU	N/A	Completed	Other	2022-03-15	2024-08-29	Treatments
NCT04238429	Toothpaste whitenning	N/A	Completed	Other	2018-09-28	2020-02-07	Primary Endpoints\|Treatments
NCT03030703	SPPhyticAcidTrial	N/A	Completed	Anemia, Iron-Deficiency	2016-12-10	2019-03-21	Treatments
NCT02751320	NCT02751320	N/A	Completed	Dental Caries	2016-07-01	2019-03-20
NCT02370940	IPAAD Study	N/A	Completed	Anemia	2013-04-01	2019-03-20	Treatments
NCT00754390	GFHNRC042	N/A	Completed	Other	2006-05-01	2025-02-07	Primary Endpoints\|Treatments
NCT02081287	Inositol Hexaphosphate	P1	Completed	Bipolar Disorder	2018-07-30	2019-03-20	Treatments
NCT01000233	CALCIFICA	P3	Unknown status	Heart Valve Diseases\|Calcinosis\|Aortic Diseases\|Aortic Valve Stenosis	2012-03-01	2019-03-19	Treatments
ACTRN12617000349347	PERT	P4	Not yet recruiting	Hypotension\|Exocrine Pancreatic Insufficiency	2018-06-01	2024-08-29	Treatments

Recent News Events

Date	Type	Title
01/24/2025	News Article	High Protein-Based Food Market to Grow by USD 50.2 Billion (2024-2028), Preference for Natural and Herbal Products Fuels Growth, Report on AI-Redefined Landscape - Technavio
05/15/2024	PubMed	Chitosan Phytate Nanoparticles: A Synergistic Strategy for Effective Dental Caries Prevention.
05/13/2024	PubMed	An up-scaled biotechnological approach for phosphorus-depleted rye bran as animal feed.
05/13/2024	PubMed	Durable and Robust Antibacterial Polypropylene Hernia Mesh for Abdominal Wall Defect Repair.
10/11/2023	News Article	Feed Phosphate Market Size is Anticipated to Grow USD 2,696.1 million at a CAGR of 4.1% by 2033 - Report by Persistence Market Research
09/07/2023	News Article	A brief description on Electrolyte Additives market with a projected CAGR of 8.9% in a specific geographic region from 2023 to 2030
09/05/2023	News Article	Middle East Feed Enzymes Market Growing Demand to Boost the Market Growth 2031

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions

Session Expiring Soon

Fytic acid

Alternative Names: fytic acid, phytic acid, phytate, phytine Clinical Status: Inactive Latest Update: 2025-01-24 Latest Update Note: News Article